Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with Trodelvy, Gilead's Trop-2 directed ADC, in ...

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced financial results for the quarter and full ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Azstarys (serdexmethylphenidate/dexmethylphenidate) is a prescription drug that’s taken to treat ADHD. The drug comes as an oral capsule that you take once per day ...

Gilead’s Trodelvy has another string to its bow after ... The US pharma hopes that the drug will be used in those patients who have not responded to treatment with immunotherapy such as Merck ...

This helps maintain a steady level of the drug in your body so Qulipta can work effectively. If you have trouble swallowing tablets, see this article for tips on how to take this form of medication.

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

The policy, which was put in place in 2018, encourages fierce competition between drug manufacturers and has ... those of the same drugs in generic form and found too many similarities, raising ...

In other cases they could appoint a lead to ensure controlled drug governance arrangements are in place. This form is protected. Contact us at enquiries@cqc.org.uk with your name, role and ...